Lynas vs Capricorn: Two ASX Buy Ratings, Two Risk Profiles

Two ASX miners reported FY26 results in the same August reporting season, and they share almost nothing in common on the commodity side. Lynas Rare Earths produces the magnetic materials that go into EV motors and wind turbines. Capricorn Metals produces gold. One is funding a multi-billion-dollar expansion programme. The other just lifted its dividend.

What they do share is a UBS Buy rating with double-digit implied upside. Lynas carries a $22.50 price target against a market price of roughly $16.19, implying approximately 39% upside. Capricorn carries a $20.25 target against approximately $17.42, implying roughly 16% upside. Both delivered headline numbers strong enough to justify a closer look, but the investment cases behind those numbers are fundamentally different.

Here is what separates the two, and how to decide which (if either) fits your portfolio based on what each stock is actually asking you to believe.

Lynas delivers record revenue but the real story is what the $932 million raise is buying

Lynas posted $977.9 million in revenue for FY26, an all-time record, driven by record average pricing across all rare earths product categories during the year. At $222.4 million, net profit fell short of what the market had anticipated, even as the top line hit new highs.

That gap between a record top line and a profit miss matters, but it is not the centre of the investment case. The real weight sits with the $932 million equity raise completed during the year (including a $182 million Share Purchase Plan component, fully underwritten), which funds the company’s Towards 2030 growth strategy.

What the Towards 2030 strategy actually targets

The programme is structured in two phases:

• Harvest phase: Optimising and ramping existing assets built under the Lynas 2025 programme, generating returns from capital already deployed.
• Grow phase: Expanding NdPr separation capacity to approximately 12,000 tonnes per annum, building out heavy rare earth separation (dysprosium and terbium), extending the Mt Weld resource base, and moving downstream into metals and magnets.

The strategic rationale is straightforward. Western governments, including the US, European Union, Japan, and Australia, are actively legislating and funding non-Chinese critical mineral supply chains. Lynas is the largest rare earths producer and processor outside China, and the Towards 2030 programme is designed to capture that structural demand from EVs, wind turbines, and defence applications.

The critical minerals supply chain pressure driving Western government policy is not a single regulatory event but a structural realignment, with the US, EU, Japan, and Australia all moving simultaneously to reduce dependence on Chinese processing capacity across rare earths, lithium, and cobalt.

The RBA analysis of Australia’s Critical Minerals Strategy documents the Australian Government’s funding facilities, the Future Made in Australia plan, and the bilateral agreement with the United States to secure non-Chinese rare earths supply chains, confirming the policy architecture that underpins Lynas’s strategic positioning.

The Malaysian operating licence renewal for 10 years provides regulatory certainty for a key processing hub. But the scale of the expansion introduces material execution risk: scaling NdPr separation to 12,000 tpa, integrating downstream, and managing Malaysian political and environmental exposure all sit between today’s share price and the UBS target.

UBS 12-month price target: $22.50 vs market price of approximately $16.19, implying roughly 39% upside. That target is a function of the expansion delivering, not of what Lynas earned last year.

When you look at Lynas, you are not evaluating an FY26 earnings beat. You are evaluating whether a multi-year, capital-intensive expansion programme can execute on schedule while rare earths pricing supports the economics. The financing step is done. Delivery is still ahead.

Capricorn Metals’ 59% profit jump and what the Karlawinda expansion unlocks in FY27

Capricorn Metals delivered the cleaner result. Full-year sales revenue reached $769.3 million, a 46% increase on the prior year, while net profit climbed 59% to $327.2 million. Production reached a record 123,589 ounces at an all-in sustaining cost (AISC, the total cost of producing each ounce including mine-site sustaining capital) of A$1,629 per ounce. Shareholders received a fully franked dividend of 5 cents per share.

59% net profit growth on the back of record production and elevated gold prices. That is the kind of result that validates a growth narrative rather than raising questions about it.

UBS described the result as broadly in line with expectations. According to UBS, the modest EBITDA shortfall reflected higher costs in corporate and exploration activities, which the broker viewed as investment supporting future growth rather than evidence of any lasting cost deterioration.

The analytical weight in this section, though, belongs to FY27. Capricorn has set FY27 output guidance of 137,000 to 147,000 ounces, with an AISC range of A$1,900 to A$2,100 per ounce. That output range sits roughly 18% above FY26 guidance at the midpoint, with the Karlawinda Expansion Project (KEP) scheduled to commission in Q1 FY27 as the primary driver.

If KEP ramps on schedule, the earnings trajectory is visible and the UBS target of $20.25 (versus approximately $17.42 at the time of publication) becomes achievable without requiring any gold price tailwind beyond current levels. That is a simpler set of assumptions than the ones Lynas requires.

Two commodities, two risk profiles: how to read the investment case for each

The commodity sitting behind each company is not background context. It is the primary variable that determines whether either UBS target is achievable, and understanding which risk factors sit outside management’s control is where the analytical work lives.

Lynas operates in rare earths, specifically NdPr (neodymium-praseodymium, the magnetic materials used in EV motors, wind turbines, and defence applications). The structural tailwind is genuine: Western policy is actively pushing for non-Chinese supply chains, and Lynas is the largest producer and processor outside China. The 10-year Malaysian licence renewal provides regulatory stability. But rare earths pricing is opaque relative to gold, the downstream customer base is concentrated, and geopolitical risk around Malaysian processing operations is real.

Capricorn operates in gold, a commodity with deep liquidity, transparent pricing, and a large base of ASX investors who understand it intuitively. Elevated gold prices are providing strong margin support, but Capricorn carries full exposure to the gold price cycle. The FY27 AISC midpoint of approximately A$2,000 per ounce means margins hold only if gold prices remain near current levels.

Capricorn’s FY27 margin profile illustrates a broader pattern across ASX gold producers: the gold price cycle compresses and expands margins faster than operational changes can offset, and an AISC stepping up to A$2,000 per ounce leaves limited buffer if gold prices retreat from current elevated levels.

Key risks for Lynas:

• Execution risk on the Towards 2030 expansion programme (NdPr capacity ramp, heavy rare earth facilities, downstream integration)
• Capital intensity and ongoing financing requirements
• Malaysian processing: political, regulatory, and environmental exposure
• Rare earths pricing volatility and concentrated customer base

Key risks for Capricorn:

• Full gold price cycle exposure with limited commodity diversification
• AISC step-up from A$1,629 to a guided A$1,900-A$2,100 range compressing margins if gold weakens
• KEP commissioning delays would directly affect FY27 production trajectory

The gap between Lynas’s implied upside and Capricorn’s is not a straightforward argument for Lynas. It reflects the extra risk premium the market attaches to execution-dependent, long-duration expansion programmes. The question for you is whether that premium appropriately compensates for the additional uncertainty.

What execution risk actually looks like for each company over the next 12 to 18 months

Broker price targets are forward-looking by definition. Understanding what milestones sit between today’s price and those targets allows a more grounded assessment of whether the implied upside is realistic.

For Lynas, the key variables to watch:

1. Progress on the NdPr separation capacity ramp toward the 12,000 tpa nameplate target, which represents a material increase from current capacity
2. Heavy rare earth expansion milestones (dysprosium and terbium separation)
3. Malaysian processing operations: any regulatory, political, or environmental developments
4. Downstream integration progress into metals and magnets, and early signals on offtake or customer commitments

The $932 million raise means the financing step is complete. What follows is execution, and the Towards 2030 programme’s multi-year timeline means investors need patience alongside conviction.

For Capricorn, the key variables to watch:

1. KEP commissioning progress in Q1 FY27, the single most watched near-term catalyst
2. Whether actual AISC tracks within the A$1,900 to A$2,100 guidance range as the expansion ramps
3. Gold price trajectory, the variable management cannot control
4. Exploration results that could extend mine life or add future production options

AISC context: Capricorn’s AISC is stepping up from A$1,629 per ounce in FY26 to a guided A$1,900 to A$2,100 in FY27. This reflects the absorption of expansion-related capital, not a deterioration in underlying mine economics. It is the cost of growing, not the cost of getting less efficient.

The investor profile distinction is clear. Lynas suits investors with long-duration conviction in the rare earths theme and a higher tolerance for execution, capital intensity, and geopolitical risk. Capricorn suits investors seeking near-term production growth, a franked income component, and a simpler operational story, accepting that upside is more constrained by the gold price cycle.

Which investment case fits your portfolio, and what each one is actually asking you to believe

Both stocks carry UBS Buy ratings with material implied upside. But implied upside is not a recommendation on its own; it is a reflection of how far the market price sits from the broker’s assessment of fair value, and the assumptions underpinning that assessment differ substantially between the two.

Implied upside: Lynas approximately 39%. Capricorn approximately 16%. The gap is not a scorecard. It is a measure of how much additional execution the market needs to see before repricing each stock.

What you need to believe to back Lynas:

• The Towards 2030 expansion programme executes on time and within budget
• Rare earths pricing supports the economics of a 12,000 tpa NdPr facility
• Western critical minerals policy continues to favour non-Chinese supply chains

What you need to believe to back Capricorn:

• Gold prices hold near current elevated levels
• KEP commissions on schedule in Q1 FY27, delivering the guided production step-up
• AISC remains within the A$1,900 to A$2,100 guided range during the expansion

Capricorn’s fully franked 5 cent dividend adds an income layer that Lynas does not offer. Lynas’s net profit came in below expectations despite record revenue, a signal about near-term earnings quality that investors should factor in alongside the longer-term ambition.

Capital allocation discipline separates ASX gold producers that compound shareholder returns through expansion cycles from those that dilute equity to fund growth without adequate return thresholds; Capricorn’s decision to issue a franked dividend alongside its expansion programme signals management confidence that KEP economics justify both reinvestment and income distribution simultaneously.

Both results reflect a reporting season where commodity tailwinds, rare earths pricing and gold, are generating strong top-line growth across the ASX resources sector. Both companies have articulated clear near-to-medium-term milestones, and investors following either stock will have concrete data points (KEP commissioning update, Lynas capacity ramp progress) to test against within the next two reporting cycles.

The choice is not which is better. It is which set of assumptions you have conviction in, and which risk profile sits comfortably alongside what you already hold.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.